Journal article
Low-dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS-related complex
Abstract
The efficacy, toxicity and cost of orally administered dapsone (50-100 mg/day) for prophylaxis of Pneumocystis carinii pneumonia (PCP) were evaluated in 30 patients with AIDS or AIDS-related complex (ARC). Six patients received primary and 24 secondary prophylaxis. Ten patients received a maximum dose of 100 mg/day and 20 a maximum of 50 mg/day for a median duration of 19 weeks; 22 of the 30 patients continue to receive prophylaxis as of May …
Authors
Kemper CA; Tucker RM; Lang OS; Kessinger JM; Greene SI; Deresinski SC; Stevens DA
Journal
AIDS, Vol. 4, No. 11, pp. 1145–1148
Publisher
Wolters Kluwer
Publication Date
November 1990
DOI
10.1097/00002030-199011000-00015
ISSN
0269-9370